Chronix Biomedical, Inc. Information

Chronix Biomedical, Inc. is a US-based molecular diagnostics company developing blood tests for use in cancer treatment and organ transplantation. Chronix's TherasureTM CNI Monitor for cancer uses proprietary algorithms to derive a copy number instability (CNI) score from sequencing of circulating cell-free tumour DNA (cfDNA), which can be used in the prognosis, diagnosis and monitoring of therapeutic response to cancer. Chronix TherasureTM Transplant Monitor quantifies the amount of graft derived cell-free DNA in organ recipients, to detect early rejection of organ transplants and better identify the transplant will be accepted.